🚀 VC round data is live in beta, check it out!
Lumibird Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lumibird and similar public comparables like Xvivo Perfusion, Perspective Therapeutics, Advanced Medical Solutions Group, Bioventus and more.
Lumibird Overview
About Lumibird
Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.
Founded
1970
HQ
Employees
1.1K
Website
Financials (LTM)
EV
$652M
Lumibird Financials
Lumibird reported last 12-month revenue of $268M and EBITDA of $55M.
In the same LTM period, Lumibird generated $55M in EBITDA and $19M in net income.
Revenue (LTM)
Lumibird P&L
In the most recent fiscal year, Lumibird reported revenue of $243M and EBITDA of $36M.
Lumibird expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $268M | XXX | $243M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $151M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $55M | XXX | $36M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $19M | XXX | $7M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $90M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Lumibird Stock Performance
Lumibird has current market cap of $606M, and enterprise value of $652M.
Market Cap Evolution
Lumibird's stock price is $27.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $652M | $606M | -0.5% | XXX | XXX | XXX | $0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLumibird Valuation Multiples
Lumibird trades at 2.4x EV/Revenue multiple, and 11.8x EV/EBITDA.
EV / Revenue (LTM)
Lumibird Financial Valuation Multiples
As of March 27, 2026, Lumibird has market cap of $606M and EV of $652M.
Equity research analysts estimate Lumibird's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lumibird has a P/E ratio of 32.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $606M | XXX | $606M | XXX | XXX | XXX |
| EV (current) | $652M | XXX | $652M | XXX | XXX | XXX |
| EV/Revenue | 2.4x | XXX | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 11.8x | XXX | 18.2x | XXX | XXX | XXX |
| EV/EBIT | 20.3x | XXX | 37.8x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.3x | XXX | XXX | XXX |
| P/E | 32.7x | XXX | 92.0x | XXX | XXX | XXX |
| EV/FCF | 35.8x | XXX | 40.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lumibird Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lumibird Margins & Growth Rates
Lumibird's revenue in the last 12 month grew by 11%.
Lumibird's revenue per employee in the last FY averaged $0.3M.
Lumibird's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lumibird's rule of X is 49% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Lumibird Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 47% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 49% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 55% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Lumibird Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Xvivo Perfusion | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Advanced Medical Solutions Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioventus | XXX | XXX | XXX | XXX | XXX | XXX |
| Anteris Technologies US | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lumibird M&A Activity
Lumibird acquired XXX companies to date.
Last acquisition by Lumibird was on XXXXXXXX, XXXXX. Lumibird acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lumibird
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLumibird Investment Activity
Lumibird invested in XXX companies to date.
Lumibird made its latest investment on XXXXXXXX, XXXXX. Lumibird invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lumibird
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lumibird
| When was Lumibird founded? | Lumibird was founded in 1970. |
| Where is Lumibird headquartered? | Lumibird is headquartered in France. |
| How many employees does Lumibird have? | As of today, Lumibird has over 1K employees. |
| Is Lumibird publicly listed? | Yes, Lumibird is a public company listed on Euronext Paris. |
| What is the stock symbol of Lumibird? | Lumibird trades under LBIRD ticker. |
| When did Lumibird go public? | Lumibird went public in 1997. |
| Who are competitors of Lumibird? | Lumibird main competitors are Xvivo Perfusion, Perspective Therapeutics, Advanced Medical Solutions Group, Bioventus. |
| What is the current market cap of Lumibird? | Lumibird's current market cap is $606M. |
| What is the current revenue of Lumibird? | Lumibird's last 12 months revenue is $268M. |
| What is the current revenue growth of Lumibird? | Lumibird revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Lumibird? | Current revenue multiple of Lumibird is 2.4x. |
| Is Lumibird profitable? | Yes, Lumibird is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Lumibird? | Lumibird's last 12 months EBITDA is $55M. |
| What is Lumibird's EBITDA margin? | Lumibird's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Lumibird? | Current EBITDA multiple of Lumibird is 11.8x. |
| What is the current FCF of Lumibird? | Lumibird's last 12 months FCF is $18M. |
| What is Lumibird's FCF margin? | Lumibird's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Lumibird? | Current FCF multiple of Lumibird is 35.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.